Effect of Sodium Glucose Co-Transporter 2 Inhibitors on Liver Fat Mass and Body Composition in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus

BACKGROUND AND OBJECTIVE: Sodium glucose co-transporter 2 inhibitors increase urinary glucose excretion and reduce visceral adiposity and body weight, but their efficacy on patients with nonalcoholic fatty liver disease has not been sufficiently investigated. The aim of this study was to assess the...

Descripción completa

Detalles Bibliográficos
Autores principales: Arase, Yoshitaka, Shiraishi, Koichi, Anzai, Kazuya, Sato, Hirohiko, Teramura, Erika, Tsuruya, Kota, Hirose, Shunji, Deguchi, Ryuzo, Toyoda, Masao, Mine, Tetsuya, Kagawa, Tatehiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593121/
https://www.ncbi.nlm.nih.gov/pubmed/30993553
http://dx.doi.org/10.1007/s40261-019-00785-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593121/
https://www.ncbi.nlm.nih.gov/pubmed/30993553
http://dx.doi.org/10.1007/s40261-019-00785-6

Ejemplares similares